Elanco Animal Health Incorporated (ELAN)

NYSE: ELAN · Real-Time Price · USD

24.50

+0.08 (0.33%)

At close: Sep 4, 2026, 4:00 PM EDT

24.20

-0.30 (-1.22%)

After-hours: Sep 4, 2026, 7:55 PM EDT

Elanco Animal Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	5,020	4,715	4,439	4,417	4,411	4,764
Revenue Growth	11.95%	6.22%	0.50%	0.14%	-7.41%	45.64%
Cost of Revenue	2,241	2,122	2,003	1,931	1,913	2,068
Gross Profit	2,779	2,593	2,436	2,486	2,498	2,696
Selling, General & Admin	1,512	1,423	1,308	1,280	1,259	1,395
Research & Development	371	368	344	327	321	369
Amortization of Goodwill & Intangibles	556	543	527	548	528	556
Operating Expenses	2,439	2,334	2,179	2,155	2,108	2,320
Operating Income	340	259	257	331	390	376
Interest Expense	-273	-245	-266	-286	-241	-236
Interest & Investment Income	45	45	31	9	-	-
Currency Exchange Gain (Loss)	-22	-14	-12	-40	-28	-35
Other Non Operating Income (Expenses)	16	-12	-4	-40	-10	22
EBT Excluding Unusual Items	106	33	6	-26	111	127
Merger & Restructuring Charges	-176	-158	-62	-93	-98	-336
Impairment of Goodwill	-	-	-	-1,042	-	-
Gain (Loss) on Sale of Investments	-	-	-8	-	-	-
Gain (Loss) on Sale of Assets	-	-	640	-	-	-
Asset Writedown	-71	-71	-81	-32	-81	-
Legal Settlements	-	-	-	-	-	-10
Other Unusual Items	-25	-28	-7	-2	-4	-352
Pretax Income	-166	-224	488	-1,195	-72	-571
Income Tax Expense	33	8	150	36	6	-88
Net Income	-199	-232	338	-1,231	-78	-483
Net Income to Common	-199	-232	338	-1,231	-78	-483
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	498	496	494	492	488	487
Shares Outstanding (Diluted)	498	496	497	492	488	487
Shares Change	-0.50%	-0.18%	1.02%	0.82%	0.23%	10.38%
EPS (Basic)	-0.40	-0.47	0.68	-2.50	-0.16	-0.99
EPS (Diluted)	-0.41	-0.47	0.68	-2.50	-0.16	-0.99
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	379	284	394	131	281	324
Free Cash Flow Per Share	0.76	0.57	0.79	0.27	0.57	0.67
Gross Margin	55.36%	55.00%	54.88%	56.28%	56.63%	56.59%
Operating Margin	6.77%	5.49%	5.79%	7.49%	8.84%	7.89%
Profit Margin	-3.96%	-4.92%	7.61%	-27.87%	-1.77%	-10.14%
Free Cash Flow Margin	7.55%	6.02%	8.88%	2.97%	6.37%	6.80%
EBITDA	1,007	908	879	971	1,007	1,040
EBITDA Margin	20.06%	19.26%	19.80%	21.98%	22.83%	21.83%
D&A For EBITDA	667	649	622	640	617	664
EBIT	340	259	257	331	390	376
EBIT Margin	6.77%	5.49%	5.79%	7.49%	8.84%	7.89%
Effective Tax Rate	-	-	30.74%	-	-	-
Advertising Expenses	-	314	236	207	201	248

SEC Filings: 10-K · 10-Q